[Clinical aspects of the radioimmunoassay of carcinoembryonic antigen levels in breast cancer].
The paper is concerned with the results of radioimmunoassay of the CEA level in the blood serum of 235 patients with breast cancer, 48 patients with fibrous-cystic mastopathies and 51 healthy women. In 100 patients with generalized breast cancer repeated examination of the CEA level was done during drug treatment. The authors showed a possibility to use in practice the results of radioimmunoassay of CEA in patients with breast cancer in early stages as a prognostic test as well as an additional criterion in the evaluation of drug therapeutic efficacy in patients with generalized breast cancer.
D001943:Breast Neoplasms / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005260:Female; D005348:Fibrocystic Breast Disease / Q000097:blood; D006801:Humans; D009376:Neoplasms, Hormone-Dependent / Q000097:blood; D011379:Prognosis; D011863:Radioimmunoassay
D002272:Carcinoembryonic Antigen
Nekotorye klinicheskie aspekty radioimmunologicheskogo issledovaniia urovnia rakovoémbrional'nogo antigena u bol'nykh rakom molochnoĭ zhelezy.